Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Drug Discoveries
News on new drug developments, clinical trials, and pharmaceutical breakthroughs
New Drug Approvals
Summary On September 27, 2024, the FDA approved selpercatinib (Retevmo) for advanced or metastatic medullary thyroid cancer patients with a…
Summary The U.S. Food and Drug Administration has approved Flyrcado for use in adult patients with known or suspected coronary…
Summary The FDA has approved Cobenfy capsules for the treatment of schizophrenia in adults, marking the first antipsychotic drug that…
Summary On September 25, 2024, the FDA approved osimertinib for adult patients with certain types of non-small cell lung cancer…
Summary The FDA approved Miplyffa, an oral medication for Niemann-Pick disease, type C. Miplyffa, in combination with miglustat, is approved…
Summary On September 20, 2024, the FDA approved isatuximab-irfc for adults with newly diagnosed multiple myeloma who are not…
Summary • Rybrevant (amivantamab-vmjw) was approved by the FDA for adults with non-small cell lung cancer who have EGFR mutations…
Summary The U.S. FDA has approved FluMist for self- or caregiver-administration for the prevention of influenza in individuals aged 2…
Summary Pembrolizumab (Keytruda) with pemetrexed and platinum chemotherapy was FDA-approved for treating advanced malignant pleural mesothelioma. The combination treatment showed…
Summary An updated COVID-19 vaccine has been issued by the FDA with a monovalent component that targets the Omicron variant…